2022
DOI: 10.1016/j.prdoa.2022.100136
|View full text |Cite
|
Sign up to set email alerts
|

Parkinson’s disease, treatment choice and survival over time

Abstract: Highlights Dopamine agonists were the preferred initiating treatment choice. Dopamine agonist-users had lower risk for death compared to MAO-B-users. Few patients had specialist health care contacts during the study period.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 16 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?